WHA 0.00% 48.7¢ wattle health australia limited

WHA uptrend sign begins, page-11

  1. 26,847 Posts.
    lightbulb Created with Sketch. 1841
    Three distribution partners to Chinese market:

    1. Aiyingdao (Owned by the partner, WHA's shareholder & lender: Mason)

    2. Weihai Port International, a Chinese state-owned company ($34m revenue for 3 years)

    3. ISDC  ($100m revenue for 42 months)

    2.png 21.png
    Merits:
    - Strong business partners from organic milk supply (ODFA), Chinese CNCA licensed infant formula manufacturer, Hong Kong based billionaire backed listed company, Mason;

    - Also secured $74m funding to develop CBDG JV to build organic powder dryer facility

    - CFDA/SAMR for normal cow infant formula has passed technical evaluation, pending formal approval

    - CBDG facility will have produce up to 10,000t milk powder; Blend & Pack has annual capacity of 20 million tins, Blend & Pack produced organic infant formula for Bellamy's

    Risks:
    - CFDA/SAMR approval, there are 1156 formulas being approved, Only 3 brands were rejected due to suspension of CNCA licence of their manufacturers, no other rejections so far.

    - Revenue

    - Brand awareness and promotion

    It's a speculative stock, business development has been focusing on building vertical integration, now it's time to increase Brand awareness and more importantly increasing Revenue. Once SAMR approval is received, this one is likely to attract more interest.

    GLTA.
 
watchlist Created with Sketch. Add WHA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.